Cargando…
Novel Therapy for Primary Canaliculitis: A Pilot Study of Intracanalicular Ophthalmic Corticosteroid/Antibiotic Combination Ointment Infiltration
In patients with primary canaliculitis, conservative medical therapy is associated with a high recurrence rate. Surgical treatments carry a great resolution rate but sometimes can result in the lacrimal pump dysfunction and canalicular scarring. The aim of this study is to introduce a minimally inva...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616879/ https://www.ncbi.nlm.nih.gov/pubmed/26426646 http://dx.doi.org/10.1097/MD.0000000000001611 |
_version_ | 1782396734272438272 |
---|---|
author | Xu, Jianjiang Liu, Zuguo Mashaghi, Alireza Sun, Xinghuai Lu, Yi Li, Yimin Wu, Dan Yang, Yujing Wei, Anji Zhao, Yujin Lu, Chun Hong, Jiaxu |
author_facet | Xu, Jianjiang Liu, Zuguo Mashaghi, Alireza Sun, Xinghuai Lu, Yi Li, Yimin Wu, Dan Yang, Yujing Wei, Anji Zhao, Yujin Lu, Chun Hong, Jiaxu |
author_sort | Xu, Jianjiang |
collection | PubMed |
description | In patients with primary canaliculitis, conservative medical therapy is associated with a high recurrence rate. Surgical treatments carry a great resolution rate but sometimes can result in the lacrimal pump dysfunction and canalicular scarring. The aim of this study is to introduce a minimally invasive approach, intracanalicular ophthalmic corticosteroid/antibiotic combination ointment infiltration (IOI, intracanalicular ointment infiltration), and to report our preliminary results for treating primary canaliculitis. In this retrospective, interventional case series, 68 consecutive patients with newly developed primary canaliculitis at a major tertiary eye center between January 2012 and January 2015. Thirty-six patients received conservative medical treatment alone (group 1; 36 eyes). Twenty-two patients and 10 medically uncontrolled patients from group 1 underwent IOI therapy (group 2; 32 eyes). Ten patients and 26 recurrent patients from group 1 and group 2 underwent surgery (group 3; 36 eyes). Patients were followed-up for at least 8 weeks. Clinical characteristics and outcomes were analyzed and compared. In this study, patients’ age, sex, onset location, and durations of disease among 3 groups showed no significant difference. The resolution rate in group 2 was 72.7% (16/22) for new patients and 68.8% (22/32) for gross patients, respectively, both of which are higher than that of group 1 (22.2%, 10/36) but lower than that of group 3 (100%, 36/36). Of group 3, 2 patients received 2 surgical interventions and resolved finally. Microbiological workup was available in 51 patients. The most common isolates were staphylococcus species (27.9%) and streptococcus species (20%). Canalicular laceration developed in 1 patient during the IOI procedure and 1 patient undergoing surgery. Only 2 had postoperative lacrimal pump dysfunction and 1 had canalicular scarring in group 3. The IOI may be an effective and minimally invasive technique for treating primary canaliculitis and obviate the need for further intensive surgery. |
format | Online Article Text |
id | pubmed-4616879 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-46168792015-10-27 Novel Therapy for Primary Canaliculitis: A Pilot Study of Intracanalicular Ophthalmic Corticosteroid/Antibiotic Combination Ointment Infiltration Xu, Jianjiang Liu, Zuguo Mashaghi, Alireza Sun, Xinghuai Lu, Yi Li, Yimin Wu, Dan Yang, Yujing Wei, Anji Zhao, Yujin Lu, Chun Hong, Jiaxu Medicine (Baltimore) 5800 In patients with primary canaliculitis, conservative medical therapy is associated with a high recurrence rate. Surgical treatments carry a great resolution rate but sometimes can result in the lacrimal pump dysfunction and canalicular scarring. The aim of this study is to introduce a minimally invasive approach, intracanalicular ophthalmic corticosteroid/antibiotic combination ointment infiltration (IOI, intracanalicular ointment infiltration), and to report our preliminary results for treating primary canaliculitis. In this retrospective, interventional case series, 68 consecutive patients with newly developed primary canaliculitis at a major tertiary eye center between January 2012 and January 2015. Thirty-six patients received conservative medical treatment alone (group 1; 36 eyes). Twenty-two patients and 10 medically uncontrolled patients from group 1 underwent IOI therapy (group 2; 32 eyes). Ten patients and 26 recurrent patients from group 1 and group 2 underwent surgery (group 3; 36 eyes). Patients were followed-up for at least 8 weeks. Clinical characteristics and outcomes were analyzed and compared. In this study, patients’ age, sex, onset location, and durations of disease among 3 groups showed no significant difference. The resolution rate in group 2 was 72.7% (16/22) for new patients and 68.8% (22/32) for gross patients, respectively, both of which are higher than that of group 1 (22.2%, 10/36) but lower than that of group 3 (100%, 36/36). Of group 3, 2 patients received 2 surgical interventions and resolved finally. Microbiological workup was available in 51 patients. The most common isolates were staphylococcus species (27.9%) and streptococcus species (20%). Canalicular laceration developed in 1 patient during the IOI procedure and 1 patient undergoing surgery. Only 2 had postoperative lacrimal pump dysfunction and 1 had canalicular scarring in group 3. The IOI may be an effective and minimally invasive technique for treating primary canaliculitis and obviate the need for further intensive surgery. Wolters Kluwer Health 2015-10-02 /pmc/articles/PMC4616879/ /pubmed/26426646 http://dx.doi.org/10.1097/MD.0000000000001611 Text en Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by-nd/4.0 This is an open access article distributed under the Creative Commons Attribution-NoDerivatives License 4.0, which allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author. http://creativecommons.org/licenses/by-nd/4.0 |
spellingShingle | 5800 Xu, Jianjiang Liu, Zuguo Mashaghi, Alireza Sun, Xinghuai Lu, Yi Li, Yimin Wu, Dan Yang, Yujing Wei, Anji Zhao, Yujin Lu, Chun Hong, Jiaxu Novel Therapy for Primary Canaliculitis: A Pilot Study of Intracanalicular Ophthalmic Corticosteroid/Antibiotic Combination Ointment Infiltration |
title | Novel Therapy for Primary Canaliculitis: A Pilot Study of Intracanalicular Ophthalmic Corticosteroid/Antibiotic Combination Ointment Infiltration |
title_full | Novel Therapy for Primary Canaliculitis: A Pilot Study of Intracanalicular Ophthalmic Corticosteroid/Antibiotic Combination Ointment Infiltration |
title_fullStr | Novel Therapy for Primary Canaliculitis: A Pilot Study of Intracanalicular Ophthalmic Corticosteroid/Antibiotic Combination Ointment Infiltration |
title_full_unstemmed | Novel Therapy for Primary Canaliculitis: A Pilot Study of Intracanalicular Ophthalmic Corticosteroid/Antibiotic Combination Ointment Infiltration |
title_short | Novel Therapy for Primary Canaliculitis: A Pilot Study of Intracanalicular Ophthalmic Corticosteroid/Antibiotic Combination Ointment Infiltration |
title_sort | novel therapy for primary canaliculitis: a pilot study of intracanalicular ophthalmic corticosteroid/antibiotic combination ointment infiltration |
topic | 5800 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616879/ https://www.ncbi.nlm.nih.gov/pubmed/26426646 http://dx.doi.org/10.1097/MD.0000000000001611 |
work_keys_str_mv | AT xujianjiang noveltherapyforprimarycanaliculitisapilotstudyofintracanalicularophthalmiccorticosteroidantibioticcombinationointmentinfiltration AT liuzuguo noveltherapyforprimarycanaliculitisapilotstudyofintracanalicularophthalmiccorticosteroidantibioticcombinationointmentinfiltration AT mashaghialireza noveltherapyforprimarycanaliculitisapilotstudyofintracanalicularophthalmiccorticosteroidantibioticcombinationointmentinfiltration AT sunxinghuai noveltherapyforprimarycanaliculitisapilotstudyofintracanalicularophthalmiccorticosteroidantibioticcombinationointmentinfiltration AT luyi noveltherapyforprimarycanaliculitisapilotstudyofintracanalicularophthalmiccorticosteroidantibioticcombinationointmentinfiltration AT liyimin noveltherapyforprimarycanaliculitisapilotstudyofintracanalicularophthalmiccorticosteroidantibioticcombinationointmentinfiltration AT wudan noveltherapyforprimarycanaliculitisapilotstudyofintracanalicularophthalmiccorticosteroidantibioticcombinationointmentinfiltration AT yangyujing noveltherapyforprimarycanaliculitisapilotstudyofintracanalicularophthalmiccorticosteroidantibioticcombinationointmentinfiltration AT weianji noveltherapyforprimarycanaliculitisapilotstudyofintracanalicularophthalmiccorticosteroidantibioticcombinationointmentinfiltration AT zhaoyujin noveltherapyforprimarycanaliculitisapilotstudyofintracanalicularophthalmiccorticosteroidantibioticcombinationointmentinfiltration AT luchun noveltherapyforprimarycanaliculitisapilotstudyofintracanalicularophthalmiccorticosteroidantibioticcombinationointmentinfiltration AT hongjiaxu noveltherapyforprimarycanaliculitisapilotstudyofintracanalicularophthalmiccorticosteroidantibioticcombinationointmentinfiltration |